Stories indexed under: Stem cells

Total: 149   RSSRSS feed

  • Invitrogen, WARF sign license agreement for human embryonic stem cells May 8, 2008 Invitrogen Corp. and the Wisconsin Alumni Research Foundation announced today (May 8) that they have signed a license for human embryonic stem cell (hESC) patents for the development of research tools.
  • Photo of James Thomson Time Magazine names James Thomson one of “World’s Most Influential People” May 2, 2008 Stem cell scientist James Thomson has been named one of Time magazine's "World's Most Influential People," with Shinya Yamanaka of Kyoto University. Last year, they each discovered a way to give human skin cells many of the characteristics of embryonic stem cells, an advance that avoids the destruction of embryos.
  • Stem cell pioneer Thomson elected to National Academy of Sciences April 29, 2008 Pioneering University of Wisconsin-Madison stem cell scientist James Thomson was elected today (April 29) to the National Academy of Sciences.
  • Leading scientists to highlight annual stem cell research symposium April 11, 2008 A cadre of North America's leading stem cell scientists will land in Madison April 16 for the third annual Wisconsin Stem Cell Symposium.
  • Erik Forsberg appointed executive director of WiCell Research Institute April 9, 2008 Erik Forsberg has been named to the newly created position of executive director of the WiCell Research Institute. In this position, Forsberg will direct all operations of the private, non-profit institute, a supporting organization of the University of Wisconsin-Madison that provides core services to UW-Madison stem cell researchers and operates the National Stem Cell Bank.
  • Christopher and Dana Reeve Foundation chair to speak at Stem Cell Summit April 2, 2008 Peter D. Kiernan, III, chair of the Christopher and Dana Reeve Foundation, will provide the keynote address at the World Stem Cell Summit Sept. 22-23, 2008, at the Alliant Energy Center in Madison.
  • Photo of James Thomson For stem cell scientist James Thomson, discovery trumps fame March 24, 2008 The UW scientist who first brought stem cells into the scientific spotlight — a discovery that sparked a volatile debate of political and medical ethics — doesn’t seek fame for himself. So when you are the go-to guy for everybody who wants access to James Thomson, a man who’d much rather be in the lab than in the media’s glare, you learn to say no more often than you’d like.
  • Stem cell summit to convene in Madison March 12, 2008 Researchers, business representatives, philanthropists, bioethicists and educators from around the world will be invited to Madison for the World Stem Cell Summit at the Alliant Energy Center on Sept. 22-23, 2008.
  • California company licenses WARF stem cell technology Jan. 9, 2008 BioTime, Inc. (OTCBB: BTIM) has signed a licensing agreement with the Wisconsin Alumni Research Foundation (WARF) for 173 patents and patent applications relating to human embryonic stem cell technology created by James Thomson at the University of Wisconsin-Madison.
  • Microscopic view of neural precursor cells Stem cells show power to predict disease, drug toxicity Dec. 6, 2007 For the first time, scientists have used human embryonic stem cells to predict the toxic effects of drugs and provide chemical clues to diagnosing disease.
  • Stem cell image UW-Madison scientists guide human skin cells to embryonic state Nov. 20, 2007 In a paper to be published Nov. 22 in the online edition of the journal Science, a team of University of Wisconsin-Madison researchers reports the genetic reprogramming of human skin cells to create cells indistinguishable from embryonic stem cells.
  • Reprogramming the debate: stem-cell finding alters ethical controversy Nov. 20, 2007 When University of Wisconsin-Madison researchers succeeded in reprogramming skin cells to behave like embryonic stem cells, they also began to redefine the political and ethical dynamics of the stem-cell debate, a leading bioethicist says.
  • Stem cell cultures $7.2 million grant to aid search for ALS stem cell therapy Sept. 20, 2007 With the help of a $7.2 million grant from the National Institutes of Health (NIH), a team of University of Wisconsin-Madison researchers will explore the potential of stem cells and natural growth factors to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.
  • Pipette and petri dish National Stem Cell Bank announces addition of new cell lines Sept. 7, 2007 The National Stem Cell Bank has announced that it has received select human embryonic stem cell lines from Novocell, a leading stem cell engineering company based in San Diego. With the addition of the new lines, the National Stem Cell Bank will have on deposit 14 of the 21 cell lines listed on the National Institutes of Health (NIH) federal registry.
  • Embryonic stem cells Stem cell therapy rescues motor neurons in ALS model Aug. 1, 2007 In a study that demonstrates the promise of cell-based therapies for diseases that have proved intractable to modern medicine, a team of scientists from the University of Wisconsin-Madison has shown it is possible to rescue the dying neurons characteristic of amyotrophic lateral sclerosis (ALS), a fatal neuromuscular disorder also known as Lou Gehrig's disease.
  • Pipette and petri dish UW establishes stem cell and regenerative medicine center May 17, 2007 In an effort to strengthen and sustain its leadership in the companion fields of stem cell research and regenerative medicine, the University of Wisconsin-Madison will establish a new Stem Cell and Regenerative Medicine Center.
  • State seeds stem-cell company based on UW-Madison research May 14, 2007 Governor Jim Doyle today (May 14) gave a $1 million boost to a University of Wisconsin-Madison spin-off company during a visit to the campus lab that gave birth to its technology.
  • Creator of Dolly the sheep to give public lecture in Madison May 9, 2007 Ian Wilmut, the famed Scottish biologist who created Dolly the cloned sheep, is coming to Madison and will give a public lecture on Thursday, May 17, at the Overture Center.
  • Second annual stem cell symposium to focus on heart tissue, blood diseases April 9, 2007 Several of the world's leading experts on the formation of blood and heart cells from stem cells, and clinical applications of stem cells in blood and heart diseases, will come together on Wednesday, April 18, for the second annual Wisconsin Stem Cell Symposium.
  • Sixth annual bioethics forum to tackle medical applications of research April 9, 2007 The interface among molecular biology, medical applications, law, religion and ethics will be the focus of the sixth annual international Bioethics Forum, hosted by Promega Corp.'s BioPharmaceutical Technology Center Institute (BTCI) in Fitchburg.